The European Academy of Gynaecological Surgery

Organization

Publications in OpenAlex of which a co-author is affiliated to this organization

All publications | By field | By subfield

All publications [Next]
Title DOI
Effect of melatonin and all-trans retinoic acid on the proliferation and induction of the apoptotic pathway in the culture of human breast cancer cell line MCF-7.
https://doi.org/10.1093/annonc/mdz394.052 Niraparib therapy in patients with newly diagnosed advanced ovarian cancer (PRIMA/ENGOT-OV26/GOG-3012 study)
https://doi.org/10.1007/s10397-016-0962-4 Retention of laparoscopic psychomotor skills after a structured training program depends on the quality of the training and on the complexity of the task
https://doi.org/10.1007/s00431-016-2836-1 European Academy of Paediatrics Statement: Vision zero for child deaths in traffic accidents
https://doi.org/10.1016/j.ejogrb.2019.10.037 Should we advise women that pre-labor caesarean section prevents pelvic floor dysfunction?
https://doi.org/10.1136/ijgc-2019-001172 Evaluation of surgical resection in advanced ovarian, fallopian tube, and primary peritoneal cancer: laparoscopic assessment. A European Network of Gynaecological Oncology Trial (ENGOT) group survey
https://doi.org/10.1111/igc.0b013e3181bda1a7 Carboplatin and Paclitaxel in Combination With Oral Enzastaurin in Advanced Ovarian or Primary Peritoneal Cancer Results From a Safety Lead-in Study
https://doi.org/10.1200/jco.2014.32.15_suppl.tps5618 The MEK Inhibitor in Low-Grade Serous Ovarian Cancer (MILO)/ENGOT-ov11 study: A multinational, randomized, open-label phase 3 study of binimetinib (MEK162) versus physician’s choice chemotherapy in patients with recurrent or persistent low-grade serous carcinomas of the ovary, fallopian tube, or primary peritoneum.
https://doi.org/10.1007/s00431-018-3190-2 Child trafficking in Europe: what is the paediatrician’s role?
https://doi.org/10.1007/s40037-019-0523-4 A qualitative study on harmonization of postgraduate medical education in Europe: negotiating flexibility is key
https://doi.org/10.1200/jco.2022.40.16_suppl.e17599 A deep learning solution for detection of homologous recombination deficiency in ovarian cancer using low pass whole-genome sequencing: Evaluation of the analytical performance.
https://doi.org/10.1007/s00431-018-3150-x Basic training requirements for health care professionals who care for children
https://doi.org/10.1089/lap.2018.0592 A Novel Surgical Intervention for an Uncommon Entity: Laparoscopy-Assisted Resection of a Vaginal Septum in Obstructed Hemivagina and Ipsilateral Renal Anomaly Syndrome
https://doi.org/10.3389/fped.2021.679803 EAP and ECPCP Statement Risks for Children's Health During the COVID-19 Pandemic and a Call for Maintenance of Essential Pediatric Services
https://doi.org/10.1200/jco.2021.39.15_suppl.tps5610 SIENDO/ENGOT-EN5/GOG-3055: A randomized phase 3 trial of maintenance selinexor versus placebo after combination platinum-based chemotherapy in advanced or recurrent endometrial cancer.
https://doi.org/10.1016/j.critrevonc.2022.103824 Direct and indirect effects on child neurocognitive development when maternal cancer is diagnosed during pregnancy: What do we know so far?
https://doi.org/10.1136/ijgc-2022-igcs.324 EP233/#541 Patterns of initial ovarian cancer recurrence on niraparib maintenance monotherapy in patients with no baseline evidence of disease following first-line chemotherapy: PRIMA/ENGOT-ov26/GOG-3012 post-hoc subgroup analysis
https://doi.org/10.1136/ijgc-2019-esgo.9 Niraparib therapy in patients with newly diagnosed advanced ovarian cancer after chemotherapy: PRIMA/ENGOT-OV26/GOG-3012 study
https://doi.org/10.1200/jco.2020.38.15_suppl.tps6095 Phase Ib/II trial of tisotumab vedotin (TV) ± bevacizumab (BEV), pembrolizumab (PEM), or carboplatin (CBP) in recurrent or metastatic cervical cancer (innovaTV 205/ENGOT-cx8/GOG-3024).
https://doi.org/10.1200/jco.2022.40.16_suppl.tps5603 Trial in progress update on ENGOT-cx8/GOG-3024/innovaTV 205: Addition of a new cohort with first-line (1L) tisotumab vedotin (TV) + pembrolizumab (pembro) + carboplatin (carbo) ± bevacizumab (bev) in recurrent/metastatic cervical cancer (r/mCC).
https://doi.org/10.1007/s00701-013-1861-3 Attitudes of young neurosurgeons and neurosurgical residents towards euthanasia and physician-assisted suicide
https://doi.org/10.1007/s00431-016-2805-8 Europe needs to protect children and youths against secondhand smoke
https://doi.org/10.3389/fped.2022.1006596 Repercussions of the COVID-19 pandemic on child and adolescent mental health: A matter of concern—A joint statement from EAP and ECPCP
https://doi.org/10.52711/2349-2996.2022.00097 A Study to assess the knowledge regarding self management behaviour among Type II Diabetes Mellitus patients in prevention of COVID-19 at selected area, Alappuzha District, Kerala, India
https://doi.org/10.1159/000536247 European Training Requirements in Neonatology 2021: The ESPR, EAP, and UEMS Accredited European Syllabus for Neonatal Training
https://doi.org/10.1200/jco.2023.41.16_suppl.tps5627 ENGOT-EN20/GOG-3083/xport-EC-042: A phase 3, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy after systemic therapy for patients with P53 wild-type, advanced or recurrent endometrial carcinoma.
https://doi.org/10.1152/ajpcell.1992.263.5.c978 Kinetics of nucleocytoplasmic Ca2+ transients in DDT1 MF-2 smooth muscle cells
https://doi.org/10.1067/mob.2002.120482 Nitrous oxide amniodistention compared with fluid amniodistention reduces operation time while inducing no changes in fetal acid-base status in a sheep model for endoscopic fetal surgery
https://doi.org/10.1186/s10397-017-1027-z Survey among ESGE members on leiomyosarcoma morcellation incidence
https://doi.org/10.1097/igc.0b013e31829b87da Roadmap for the European Network of Gynaecological Trial Groups (ENGOT) Trials
https://doi.org/10.1007/s10397-014-0876-y Myoma morcellation and leiomyosarcoma panic
https://doi.org/10.1093/ageing/afw086 The development of a geriatric postgraduate education assessment instrument using a modified Delphi procedure
https://doi.org/10.1136/ijgc-00009577-200409001-00441 441 Immunohistochemical Determination of CD10, Estrogen and Progesterone Receptor Positivity in Uterine Adenosarcoma
https://doi.org/10.1002/j.2205-0140.2012.tb00011.x Key findings from the International Ovarian Tumor Analysis (IOTA) study: an approach to the optimal ultrasound based characterisation of adnexal pathology
https://doi.org/10.1007/s00431-017-2894-z Health, integrity, and doping in sports for children and young adults. A resolution of the European Academy of Paediatrics
https://doi.org/10.1200/jco.2015.33.15_suppl.tps5610 The MILO (MEK inhibitor in low-grade serous ovarian cancer)/ENGOT-ov11 study: A multinational, randomized, open-label phase 3 study of binimetinib (MEK162) versus physician’s choice chemotherapy in patients with recurrent or persistent low-grade serous carcinomas of the ovary, fallopian tube, or primary peritoneum.
Confidential enquiries into quality of care of women in labour using Hypoxic Ischemic Encephalopathy as a marker.
https://doi.org/10.23885/1814-3326-2016-12-2-285-288 New and interesting Lepidoptera records from Chechen Republic (Russia). 2
https://doi.org/10.1515/crpm-2012-0054 Prenatal surgery in a triplet pregnancy complicated by a double twin reversed arterial perfusion (TRAP) sequence
https://doi.org/10.1007/s10334-019-00755-1 ESMRMB 2019, 36th Annual Scientific Meeting, Rotterdam, NL, October 3–October 5: Abstracts, Saturday
https://doi.org/10.1111/his.12396 FISH analysis ofPTENin endometrial carcinoma. comparison withSNParrays andMLPA
https://doi.org/10.1093/annonc/mdz250.072 Phase I/II trial of tisotumab vedotin plus bevacizumab, pembrolizumab, or carboplatin in recurrent or metastatic cervical cancer (innovaTV 205/ENGOT-cx8)
https://doi.org/10.1140/epjd/e2020-10135-3 Wigner scattering theory for systems held together by Coulombic forces
https://doi.org/10.1007/978-1-4471-5146-3_25 T-Shaped Uterus
https://doi.org/10.1200/jco.2022.40.16_suppl.5574 Integrated safety summary of single-agent mirvetuximab soravtansine in patients with folate receptor α (FRα)-positive recurrent ovarian cancer: Phase 1 and 3 clinical trials.
https://doi.org/10.1016/j.annonc.2022.07.654 526MO Pathological assessment of sentinel lymph node in early-stage cervical cancer: Results from the prospective SENTIX trial (CEEGOG-CX01; ENGOT-CX2)
https://doi.org/10.1016/j.esmoop.2023.100813 33O PRIMA/ENGOT-OV26/GOG-3012 study: Long-term conditional PFS
https://doi.org/10.21101/cejph.a7508 Vaccine-hesitant families are more susceptible to verbal communication messaging
https://doi.org/10.1200/jco.2023.41.36_suppl.427956 Long-term follow up of selinexor maintenance in patients with TP53wt advanced or recurrent endometrial cancer: A pre-specified subgroup analysis from the phase 3 ENGOT-EN5/GOG-3055/SIENDO study.
https://doi.org/10.1038/s41375-024-02274-y Correction: Dynamics of clonal hematopoiesis under DNA-damaging treatment in patients with ovarian cancer
https://doi.org/10.1016/s0090-8258(21)00717-4 A randomized, double-blind, placebo-controlled, phase II study to assess the efficacy/safety of farletuzumab in combination with carboplatin plus paclitaxel or carboplatin plus pegylated liposomal doxorubicin (PLD) in women with low CA-125 platinum-sensitive ovarian cancer
https://doi.org/10.1007/s13224-023-01795-3 Laparoscopic Management of Second Trimester Vesico Uterine Rupture
https://doi.org/10.3389/fped.2024.1418552 Teenage parents and their children—position paper of the European academy of paediatrics and the European confederation of primary care paediatricians
https://doi.org/10.1016/j.annonc.2024.08.2268 LBA29 Final overall survival (OS) in patients (pts) with newly diagnosed advanced ovarian cancer (aOC) treated with niraparib (nir) first-line (1L) maintenance: Results from PRIMA/ENGOT-OV26/GOG-3012
https://doi.org/10.1016/j.ijgc.2024.100081 Longer-Term Safety And Efficacy Of Selinexor Maintenance Therapy For Patients With TP53wt Advanced Or Recurrent Endometrial Cancer: Follow-Up Subgroup Analysis Of The ENGOT-EN5/GOG-3055/SIENDO Study
https://doi.org/10.1002/ijgo.70139 Pregnancy after cancer: FIGO Best practice advice
https://doi.org/10.1113/jphysiol.1990.sp018166 Agonist‐dependent Ca2+ and Mn2+ entry dependent on state of filling of Ca2+ stores in aortic smooth muscle cells of the rat.
https://doi.org/10.1152/jappl.1987.63.4.1493 Effects of acute hyperinflation on chest wall mechanics in dogs
https://doi.org/10.1016/s0140-6736(15)60745-0 Improving paediatric care in the community
https://doi.org/10.1093/humrep/den162 Modern endoscopic-based exploration of the female reproductive tract: a model for developing countries?
https://doi.org/10.1016/j.ejogrb.2016.10.003 Standards of Care in infertility in Europe
https://doi.org/10.1007/978-3-319-69974-5_1 Is Progress in Science, Progress for Society?
https://doi.org/10.1136/ijgc-2021-igcs.177 EPV107/#258 ENGOT-EN11/GOG-3053/KEYNOTE-B21: phase 3 study of pembrolizumab or placebo in combination with adjuvant chemotherapy with/without radiotherapy in patients with newly diagnosed high-risk endometrial cancer
https://doi.org/10.1136/ijgc-2022-esgo.884 2022-RA-1136-ESGO A single-cell map of rare ovarian cancer
https://doi.org/10.1200/jco.2023.41.16_suppl.tps5615 A randomized trial of olaparib, durvalumab, and cancer vaccine, UV1, as maintenance therapy in patients with BRCAwt with recurrent ovarian cancer: ENGOT-OV56/NSGO-CTU-DOVACC trial.
https://doi.org/10.1200/jco.2024.42.16_suppl.5531 Tisotumab vedotin in 2L/3L recurrent or metastatic cervical cancer: Subsequent therapy data from ENGOT-cx12/GOG-3057/innovaTV 301.
https://doi.org/10.1111/bcp.16325 Population pharmacokinetics and exposure–response relationships of dostarlimab in primary advanced or recurrent endometrial cancer in part 1 of RUBY
https://doi.org/10.1097/igc.0000000000001053 Orientation of Preclinical Research in Ovarian Cancer
https://doi.org/10.1136/ijgc-2022-esgo.139 2022-RA-1548-ESGO Trial in progress update on ENGOT-cx8/GOG-3024/innovaTV 205: addition of a new cohort using first-line tisotumab vedotin + pembrolizumab + carboplatin ± bevacizumab in recurrent/metastatic cervical cancer
https://doi.org/10.1111/apa.17336 EAP statement: Communicating air pollution risks to children and families
https://doi.org/10.1016/j.preghy.2024.101156 Clinical maternal risk parameters for the occurrence of maternal and fetal complications during preeclampsia in Congolese women
https://doi.org/10.1016/j.annonc.2024.08.794 732P Durvalumab + carboplatin/paclitaxel (CP) followed by durvalumab ± olaparib as a first-line treatment for endometrial cancer (EC): Progression-free survival (PFS) by clinical factors in DUO-E
https://doi.org/10.1016/j.annonc.2024.08.793 731P Post-progression survival outcomes in patients (pts) with primary advanced or recurrent endometrial cancer (pA/rEC) in the ENGOT-EN6-NSGO/GOG-3031/RUBY trial who received follow-up immunotherapy
https://doi.org/10.1136/ijgc-2024-005697 Gender equality, diversity, and inclusion among gynaecologic oncologists: European Network of Young Gynae Oncologists (ENYGO)–European Society of Gynaecological Oncology (ESGO) project
https://doi.org/10.1136/ijgc-2024-igcs.16 PO003/#1168  Longer-term safety and efficacy of selinexor maintenance therapy for patients with TP53WT advanced or recurrent endometrial cancer: follow up subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study
https://doi.org/10.1016/j.ijgc.2024.100098 Quality-Adjusted Time Without Symptoms Of Disease Progression Or Toxicity Analysis Of Mirvetuximab Soravtansine Versus Investigator’s Choice Of Chemotherapy In Folate Receptor-Alpha Positive, Platinum-Resistant Ovarian Cancer
https://doi.org/10.1016/j.ijgc.2025.101701 Durvalumab Plus Carboplatin/Paclitaxel Followed By Durvalumab As First-Line Treatment For Endometrial Cancer: Patient-Reported Outcomes In The DUO-E/GOG-3041/ENGOT-EN10 Intent-To-Treat And Mismatch Repair Deficient Populations
https://doi.org/10.1016/j.ijgc.2025.101700 Pembrolizumab Or Placebo Plus Adjuvant Chemotherapy With Or Without Radiotherapy In Patients With Newly Diagnosed, High-Risk Endometrial Cancer: Exploratory Analysis Of Disease-Specific Survival From The Phase 3 ENGOT-En11/GOG-3053/KEYNOTE-B21 Study
https://doi.org/10.1016/j.ijgc.2025.101702 Durvalumab Plus Carboplatin/Paclitaxel Followed By Durvalumab Plus Olaparib As First-Line Treatment For Endometrial Cancer: Patient-Reported Outcomes In The DUO-E/GOG-3041/ENGOT-EN10 Intent-To-Treat And Mismatch Repair Proficient Populations
https://doi.org/10.1038/s41416-025-03012-6 Single-cell profiling in ovarian germ cell and sex cord-stromal tumours
https://doi.org/10.1016/j.currproblcancer.2025.101207 Diagnostic accuracy of intraoperative frozen section in endometrial cancer: Correlation with final histopathology
https://doi.org/10.1016/j.esmoop.2025.105204 75MO Efficacy and safety of rucaparib maintenance treatment in patients from ATHENA-MONO/GOG-3020/ENGOT-ov45 with newly diagnosed advanced ovarian cancer not associated with homologous recombination deficiency
https://doi.org/10.1111/apa.70311 Sport Activities for Children and Adolescents: Part 2. Joint Position Statement of Paediatric Societies on Physical Activity and Sport Recommendations for Children With Specific Chronic Disease Conditions
https://doi.org/10.1016/j.annonc.2025.09.057 LBA45 ROSELLA (GOG3073, ENGOTov72, APGOT-OV10): Relacorilant + nab-paclitaxel in the subgroup of patients with platinum-resistant ovarian cancer (PROC) previously exposed to a PARP inhibitor
Radiological aspects of Zenker's diverticulum.
Rhabdomyosarcoma of the corpus of the uterus: a case report.
Ca(2+)-transport ATPases and Ca(2+)-compartments in smooth muscle cells.
Neuro-cognitive and behavioural aspects in non-specific mental retardation. A proposal for phenotyping new XLMR genes.
https://doi.org/10.1097/00003643-200406000-00007 Low-dose combined spinal-epidural anaesthesia vs. conventional epidural anaesthesia for Caesarean section in pre-eclampsia: a retrospective analysis
https://doi.org/10.1586/17434440.2015.1015988 Economic and clinical benefits of radiofrequency ablation versus hysterectomy in patients suffering from menorrhagia: a retrospective analysis with German health claims data
https://doi.org/10.1097/ogx.0b013e3181e57422 A Valid Model for Testing and Training Laparoscopic Psychomotor Skills
https://doi.org/10.1200/jco.2021.39.15_suppl.tps5596 Tisotumab vedotin versus investigator’s choice chemotherapy in second- or third-line recurrent or metastatic cervical cancer (innovaTV 301/ENGOT-cx12/GOG 3057, trial in progress).
https://doi.org/10.1111/j.1479-828x.1994.tb01110.x Clinical and Urodynamic Follow‐Up of Women with Established Urinary Dysfunction After Radical Hysterectomy
https://doi.org/10.1016/s0140-6736(15)00824-7 The rights of children arriving in Europe
https://doi.org/10.1159/000446535 Gene-Tailored Treatments for Brain Disorders: Challenges and Opportunities
https://doi.org/10.1023/a:1011268400088 Electrical characterization of shallow cobalt-silicided junctions
https://doi.org/10.1007/s10397-016-0987-8 ESGE survey on tissue power morcellation complications other than leiomyosarcoma
https://doi.org/10.1111/hsc.12790 Using the TIDieR checklist to describe health visitor support for mothers with mental health problems: Analysis of a cross‐sectional survey
https://doi.org/10.33361/rpq.2021.v.9.n.22.444 Percepção de usuários de uma unidade básica de saúde sobre dor crônica musculoesquelética e estratégias de gerenciamento da dor
https://doi.org/10.1200/jco.2022.40.16_suppl.tps5614 TEDOVA/GINECO-OV244b/ENGOT-ov58 trial: Neo-epitope based vaccine OSE2101 alone or in combination with pembrolizumab versus best supportive care (BSC) as maintenance in platinum-sensitive recurrent ovarian cancer with disease control after platinum.